Pro-Dex, Inc. (PDEX)
Stock Price:
$33.86 USD
-0.94 (-2.70%)
Updated Oct 28, 2020 4:00 PM EDT - Market closed
Key Info
| Market Cap |
130.64M |
| Revenue (ttm) |
34.83M |
| Net Income (ttm) |
6.11M |
| Shares Out |
3.86M |
| EPS (ttm) |
1.50 |
| PE Ratio |
22.57 |
| Forward PE |
24.33 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Oct 28, 2020 |
| Last Price |
$33.86 |
| Previous Close |
$34.80 |
| Change ($) |
-0.94 |
| Change (%) |
-2.70% |
| Day's Open |
34.54 |
| Day's Range |
33.76 - 35.28 |
| Day's Volume |
22,550 |
| 52-Week Range |
11.40 - 38.48 |
More Stats
| Market Cap |
130.64M |
| Enterprise Value |
128.34M |
| Earnings Date (est) |
Nov 5, 2020 |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
3.86M |
| Float |
2.74M |
| EPS (basic) |
1.56 |
| EPS (diluted) |
1.50 |
| FCF / Share |
1.13 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
4.43% |
| FCF Yield |
3.39% |
| Payout Ratio |
n/a |
| Shares Short |
20,727 |
| Short Ratio |
0.73 |
| Short % of Float |
0.76% |
| Beta |
1.43 |
| PE Ratio |
22.57 |
| Forward PE |
24.33 |
| P/FCF Ratio |
29.48 |
| PS Ratio |
3.75 |
| PB Ratio |
7.39 |
| Revenue |
34.83M |
| Operating Income |
7.07M |
| Net Income |
6.11M |
| Free Cash Flow |
4.43M |
| Net Cash |
2.30M |
| Net Cash / Share |
0.60 |
| Gross Margin |
37.73% |
| Operating Margin |
20.28% |
| Profit Margin |
17.50% |
| FCF Margin |
12.72% |
| ROA |
15.58% |
| ROE |
33.89% |
| ROIC |
31.60% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Forecasts
Analyst Ratings (0)
| Buy |
0 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
Low
30.0
Current: $33.86
High
30.0
Target: 30.00
*Average 12-month price target from 1 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|
| Revenue | 34.83 | 27.17 | 22.47 | 21.94 | 19.19 | 13.38 | 10.81 | 12.25 | 17.26 | 24.06 |
| Revenue Growth | 28.2% | 20.95% | 2.38% | 14.35% | 43.38% | 23.78% | -11.73% | -29.02% | -28.28% | - |
| Gross Profit | 13.14 | 9.78 | 7.94 | 7.19 | 4.92 | 3.70 | 2.97 | 3.72 | 5.42 | 10.14 |
| Operating Income | 7.07 | 5.00 | 2.39 | 2.74 | 0.81 | -0.90 | -0.81 | -1.90 | -1.37 | 3.48 |
| Net Income | 6.11 | 4.15 | 1.62 | 5.08 | 0.82 | -0.37 | -0.49 | -1.78 | -0.88 | 2.64 |
| Shares Outstanding | 3.91 | 4.19 | 4.30 | 4.04 | 4.14 | 4.17 | 3.49 | 3.32 | 3.27 | 3.26 |
| Earnings Per Share | 1.50 | 0.97 | 0.37 | 1.25 | 0.20 | -0.09 | -0.14 | -0.54 | -0.27 | 0.85 |
| EPS Growth | 54.64% | 162.16% | -70.4% | 525% | - | - | - | - | - | - |
| Operating Cash Flow | 4.95 | 3.33 | 3.10 | 3.24 | 0.47 | -0.78 | -0.33 | -1.27 | 0.05 | 2.90 |
| Capital Expenditures | -0.51 | -1.38 | -0.89 | -0.60 | -0.29 | -0.24 | -0.05 | -0.09 | -0.26 | -0.27 |
| Free Cash Flow | 4.43 | 1.95 | 2.20 | 2.63 | 0.17 | -1.02 | -0.38 | -1.36 | -0.21 | 2.63 |
| Cash & Equivalents | 8.98 | 9.45 | 8.58 | 4.92 | 2.29 | 0.70 | 3.19 | 1.68 | 4.11 | 4.69 |
| Total Debt | 6.68 | 4.56 | 0.04 | 0.12 | 0.07 | 0.10 | 0.02 | 0.02 | 0.77 | 1.13 |
| Net Cash / Debt | 2.30 | 4.90 | 8.54 | 4.80 | 2.22 | 0.60 | 3.17 | 1.66 | 3.34 | 3.56 |
| Assets | 31.13 | 25.52 | 19.92 | 16.35 | 11.15 | 12.52 | 11.71 | 10.60 | 12.82 | 15.56 |
| Liabilities | 12.06 | 8.51 | 2.64 | 2.64 | 2.27 | 4.04 | 2.49 | 2.66 | 3.27 | 5.24 |
| Book Value | 19.06 | 17.01 | 17.28 | 13.71 | 8.88 | 8.48 | 9.22 | 7.94 | 9.55 | 10.32 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Pro-Dex, Inc. |
| Country |
United States |
| Employees |
117 |
| CEO |
Richard Lee Van Kirk |
Stock Information
| Ticker Symbol |
PDEX |
| Stock Exchange |
NASDAQ |
| Sector |
Healthcare |
| Industry |
Medical Instruments & Supplies |
| Unique Identifier |
NASDAQ: PDEX |
Description
Pro-Dex designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and maxocranial facial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.